Bellapelle GmbH operates within the healthcare and medical technology industry, specializing in the development and production of synthetic skin substitutes. The company focuses on providing advanced wound care solutions designed to support tissue regeneration and aid in the treatment of chronic and acute wounds. Its products are primarily intended for healthcare professionals and institutions involved in wound management, including hospitals, clinics, and specialized care providers. Bellapelle’s offerings aim to contribute to improved patient outcomes by addressing complex wound healing challenges through innovative biomaterials and medical applications.